Table 1.
Method | Nanoparticle Use | Detected Antigen | Detection Method | Lower Limit of Detection | Substrates Tested | Ref. |
---|---|---|---|---|---|---|
Conventional methods | - | Anti-HBsAg | ELISA | Plasma, serum | [73] | |
- | HBsAg | ELISA | 0.5 IU/mL | Plasma, serum | [19] | |
- | HBV DNA | PCR | 2000 IU/mL | Plasma, serum | [74] | |
Gold nanoparticles | DNA-coated AuNP | HBsAg | Direct detection of SPR peak | 0.1 IU/mL | Blood, serum, plasma | [26] |
DNA-coated AuNP | HBV DNA | Voltammetry | 2 × 10−9 M | PCR product | [37] | |
Anti-HBs and HAT-coated AuNP | HBsAg | FELISA | 5 × 10−4 IU/mL | HBsAg in PBS | ||
Oligo-coated AuNP | DNA | Colorimetric, disposable paper strips | 1 × 10−9 M | N.A. | [27] | |
Oligo-coated AuNP | HBV DNA | Colorimetric, dark-field microscope | 1 × 10−13 M | PCR product | ||
HBsAg | Electrochemical | 0.343 pg/mL | [36] | |||
Gold Nanostructure | HBsAg | SERS | 0.01 IU/mL | Serum | [46] | |
Oligo-coated AuNP | HBV DNA | Electrochemical (impedance) | 111 copies/mL | Serum | [35] | |
Magnetic nanoparticles | Immobilised, probe-conjungated NP | HBV DNA | Non-faradic impedance spectroscopy | 50 pMol in 20 µL; 2.5 × 10−6 M | Plasma and serum | [63] |
Anti-HBsAg coated MNP | HBsAg | (cyclic) voltammetry | 0.9 pg/mL | HBsAg in PBS | [60] | |
QDs | HBsAg-coated QDs | Anti-HBsAg | Lateral flow | 2 pg/mL | Anti-HBsAg | [67] |
Magnetite and gold nanoparticles | Immobilised gold NP, competition between target DNA and MNP | HBV DNA | RCT | 3.1 (±0.1) × 10−13 M | Urine, plasma | [72] |
Anti-HBsAg coated MNP and AuNP aggregation | HBsAg | Anodic stripping voltammetry | 87 pg/mL | HBsAg in PBS | [75] | |
AuNPs and QDs | Immobilised QD, competition between target DNA and AuNP | Simultaneous HBV DNA and HCV RNA | Colorimetric, ECL quenching | 8.2 × 10−14 M (HBV) and 3.4 × 10−13 M (HCV) | Plasma | [76] |
ELISA: enzyme-linked immunosorbent assay; HBeAg: hepatitis B virus e antigen; HBsAg: hepatitis B virus surface antigen; RCT: interfacial charge transfer resistance; QDs: quantum Dots; HAT: human alpha-thrombin; HCV: hepatitis C virus; SPR: surface plasmon resonance; FELISA: fluorescence enzyme-linked immunosorbent assay; SERS: surface enhanced Raman spectroscopy; ECL: electrochemiluminescence; PBS: phosphate-buffered saline; N.A.: non applicable.